Multi-kinase targeted therapy as a promising treatment strategy for ovarian tumors expressing sfRon receptor

The sfRon kinase is an important therapeutic target in ovarian cancer that contributes to prominent tumor growth and disease progression. We reasoned that a multi-kinase inhibition of sfRon pathway might be an effective strategy to achieve a sustained anti-tumor response, while simultaneously preven...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Luyao, Wang, Lin, Cybula, Magdalena, Drumond-Bock, Ana Luiza, Moxley, Katherine M., Bieniasz, Magdalena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805538/
https://www.ncbi.nlm.nih.gov/pubmed/33488949
http://dx.doi.org/10.18632/genesandcancer.205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805538/
https://www.ncbi.nlm.nih.gov/pubmed/33488949
http://dx.doi.org/10.18632/genesandcancer.205

Ejemplares similares